AcquisitionOther
Sun Pharmaceutical Industries, Inc. acquired Checkpoint Therapeutics, Inc.
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Sun Pharmaceutical Industries, Inc. -> Checkpoint Therapeutics, Inc. · up to $355 million
To acquire Checkpoint's immunotherapy and targeted oncology company, adding UNLOXCYT, an FDA-approved anti-PD-L1 treatment for advanced cutaneous squamous cell carcinoma, to Sun Pharma's global onco-derm franchise
Open source record (SEC) ↗